MARKET

ADMA

ADMA

ADMA Biologics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.140
+0.090
+2.22%
Closed 16:33 11/15 EST
OPEN
4.060
PREV CLOSE
4.050
HIGH
4.200
LOW
3.950
VOLUME
639.09K
TURNOVER
--
52 WEEK HIGH
6.31
52 WEEK LOW
2.080
MARKET CAP
187.61M
P/E (TTM)
-3.7067
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ADMA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ADMA News

  • ADMA Biologics to Present at Jefferies 2019 London Healthcare Conference
  • GlobeNewswire.4d ago
  • Here's Why ADMA Biologics (NASDAQ:ADMA) Can Afford Some Debt
  • Simply Wall St..11/08 10:33
  • ADMA Biologics EPS beats by $0.04, beats on revenue
  • seekingalpha.11/07 03:36
  • ADMA Biologics Q3 EPS $(0.19) Up From $(0.33) YoY, Sales $7.2M Up From $4.23M YoY
  • Benzinga.11/06 22:35

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About ADMA

ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include Plasma Collection Centers, which includes its operations in Georgia; Research and Development, which includes its plasma development operations in New Jersey, and Corporate. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its intravenous immunoglobulin product candidate, RI-002, is intended for the treatment of primary immune deficiency disease.
More

Webull offers ADMA Biologics Inc (ADMA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.